SEC Comment Letter for Ernexa Therapeutics Inc. (ERNA, ERNAW) (CIK 0000748592) (ERNA) — Mar 25, 2008

Ernexa Therapeutics Inc. (ERNA, ERNAW) (CIK 0000748592)
Date: March 25, 2008 · CIK: 0000748592 · Accession: 0000000000-08-015498

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 001-11460

Date

March 25, 2008

Author

Larry Spirgel

Form

UPLOAD

Company

Ernexa Therapeutics Inc. (ERNA, ERNAW) (CIK 0000748592)

Letter

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 DIVISION OF CORPORATION FINANCE Mail Stop 3720 March 25, 2008 Via U.S. Mail and Fax (1-760-929-5280) Kendra Berger Chief Financial Officer NTN Buzztime, Inc. 5966 La Place Court Carlsbad, California, 92008 Re: NTN Buzztime, Inc. Form 10-K for Fiscal Year Ended December 31, 2006 Filed March 16, 2007 Forms 10-Q for Fiscal Quarter Ended September 30, 2007 File No. 001-11460

Dear Ms. Berger: We have completed our review of your Form 10-K and related filings and do not, at this time, have any further comments.

S i n c e r e l y , L a r r y S p i r g e l A s s i s t a n t D i r e c t o r

Show Raw Text

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

       DIVISION OF
CORPORATION FINANCE

Mail Stop 3720

       March 25, 2008

Via U.S. Mail and Fax (1-760-929-5280)
Kendra Berger
Chief Financial Officer  NTN Buzztime, Inc. 5966 La Place Court Carlsbad, California, 92008
 Re: NTN Buzztime, Inc.
Form 10-K for Fiscal Year Ended December 31, 2006
  Filed March 16, 2007

Forms 10-Q for Fiscal Quarter Ended September 30, 2007
  File No. 001-11460

Dear Ms. Berger:  We have completed our review of your Form 10-K and related filings and do not, at this time, have any further comments.

         S i n c e r e l y ,             L a r r y  S p i r g e l          A s s i s t a n t  D i r e c t o r

SecProbe.io